Single nucleotide polymorphisms in angiogenesis-related genes and outcomes from antiangiogenic therapies in renal cell carcinoma: really a step towards personalized oncology, or not at all?

Ann Transl Med. 2019 Mar;7(Suppl 1):S15. doi: 10.21037/atm.2019.01.51.

Authors

Camillo Porta^{1

2}, Laura Cosmai³, Mimma Rizzo², Mario Melazzini⁴

Affiliations

¹ Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
² Division of Translational Oncology, I.R.C.C.S. Istituti Clinici Scientifici Maugeri, Pavia, Italy.
³ Division of Nephrology and Dialysis, A.S.S.T. Santi Paolo e Carlo, San Carlo Borromeo Hospital, Milan, Italy.
⁴ Scientific Direction, I.R.C.C.S. Istituti Clinici Scientifici Maugeri, Pavia, Italy.

No abstract available

Publication types

Editorial
Comment